Compound Summary


6-bromoindirubin-3′-oxime-piperazine
  Experimental Data
 6-bromoindirubin-3′-oxime-piperazine

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Drosophila melanogaster 50.000000000000000 umol/L 48.000000000000000 54.000000000000000 12.500000000000000 74.000000000000000 70.000000000000000 -0.050000000000000 S w1118 28253732 Active
Drosophila melanogaster 100.000000000000000 umol/L 48.000000000000000 50.000000000000000 4.170000000000000 74.000000000000000 67.000000000000000 -0.090000000000000 NS w1118 28253732 Inactive
Drosophila melanogaster 150.000000000000000 umol/L 48.000000000000000 51.000000000000000 6.250000000000000 74.000000000000000 70.000000000000000 -0.050000000000000 NS w1118 28253732 Inactive
Drosophila melanogaster 200.000000000000000 umol/L 48.000000000000000 47.000000000000000 -2.080000000000000 74.000000000000000 65.000000000000000 -0.120000000000000 NS w1118 28253732 Inactive
  Experimental Data Visualization
 6-bromoindirubin-3′-oxime-piperazine

  Statistics Data
 6-bromoindirubin-3′-oxime-piperazine

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Drosophila melanogaster 12.500000000000000 -0.050000000000000 1 4
  Statistics Data Visualization
 6-bromoindirubin-3′-oxime-piperazine